Rare Germline Variant in NFATC4 Associated with Familial Chronic Lymphocytic Leukemia von Itchaki, Gilad, Tiao, Grace, Improgo, Ma Reina D., Kasar, Siddha, Tesar, Bethany, Fernandes, Stacey Marie, Pochet, Nathalie, McWilliams, Emily M, Bai, Harrison, Freedman, Arnold S., Getz, Gad, Brown, Jennifer R.

Volltext

Efficacy Results of a Phase 2 Trial Evaluating Idelalisib Plus Ofatumumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia von Lampson, Benjamin L., Kim, Haesook T, Davids, Matthew S., Abramson, Jeremy S., Freedman, Arnold S., Jacobson, Caron A., Armand, Philippe, Joyce, Robin M., Arnason, Jon E., Rassenti, Laura Z., Kipps, Thomas J., Huang, Samantha, Fein, Joshua, Hanna, John, Fernandes, Stacey Marie, Fisher, David C., Brown, Jennifer R.

Volltext

Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia von Thijssen, Rachel, ter Burg, Johanna, Garrick, Brett, van Bochove, Gregor G.W., Brown, Jennifer R., Fernandes, Stacey M., Rodríguez, María Solé, Michot, Jean-Marie, Hallek, Michael, Eichhorst, Barbara, Reinhardt, Hans Christian, Bendell, Johanna, Derks, Ingrid A.M., van Kampen, Roel J.W., Hege, Kristen, Kersten, Marie José, Trowe, Torsten, Filvaroff, Ellen H., Eldering, Eric, Kater, Arnon P.

Volltext